UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Applications of Physiologically Based Pharmacokinetic Modeling: Perspectives on the Advantages and Challenges

Therapeutic drug monitoring, 2020-02, Vol.42 (1), p.157-158

2020

Volltextzugriff (PDF)

Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches

Journal of clinical pharmacology, 2021-07, Vol.61 (7), p.857-870

2021

Volltextzugriff (PDF)

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

Clinical pharmacokinetics, 2021-02, Vol.60 (2), p.249-259

2021

Volltextzugriff (PDF)

Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients

Journal of clinical pharmacology, 2020-04, Vol.60 (4), p.453-465

2020

Volltextzugriff (PDF)

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics

Expert opinion on drug metabolism & toxicology, 2021-01, Vol.17 (1), p.87-103

2021

Volltextzugriff (PDF)

The immature rat as a potential model for chemical risks to children: Ontogeny of selected hepatic P450s

Chemico-biological interactions, 2016-08, Vol.256, p.167-177

2016

Volltextzugriff (PDF)

Molecular characterization of PoGT8D and PoGT43B, two secondary wall-associated glycosyltransferases in poplar [Populus]

Plant and cell physiology, 2007-05, Vol.48 (5), p.689-699

2007

Volltextzugriff (PDF)

Utilizing pediatric PBPK models to examine factors which contribute to methadone pharmacokinetic variability in neonatal abstinence syndrome patients

Journal of clinical pharmacology, 2019-12, Vol.60 (4), p.453-465

2019

Volltextzugriff (PDF)

The PARVUS gene is expressed in cells undergoing secondary wall thickening and is essential for glucuronoxylan biosynthesis

Plant and cell physiology, 2007-12, Vol.48 (12), p.1659-1672

2007

Volltextzugriff (PDF)

Sex Differences in Demographic and Pharmacological Factors in Alzheimer Patients With Dementia and Cognitive Impairments

Frontiers in behavioral neuroscience, 2022-04, Vol.16, p.828782-828782

2022

Volltextzugriff (PDF)

“I realized I was not alone”: A mixed-methods investigation of the implementation of Ubuntu groups to reduce burnout and social isolation in an allopathic medical School in the Southeastern United States

Medical teacher, 2024-03, p.1-11

2024

Volltextzugriff (PDF)

American Society for Pharmacology and Experimental Therapeutics Division for Pharmacology Education at EB2022—Meeting report

Pharmacology research & perspectives, 2022-10, Vol.10 (5), p.e01014-n/a

2022

Volltextzugriff (PDF)

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial

Trials, 2024-04, Vol.25 (1), p.265-265, Article 265

2024

Volltextzugriff (PDF)

Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer's Disease

Brain sciences, 2022-01, Vol.12 (2), p.160

2022

Volltextzugriff (PDF)

An Adaptive Blended Learning Model for the Implementation of an Integrated Medical Neuroscience Course During the Covid‐19 Pandemic

Anatomical sciences education, 2021-11, Vol.14 (6), p.699-710

2021

Volltextzugriff (PDF)

Abstract 1122‐000036: Demographic and Pharmacological Characteristics of Alzheimer Dementia Patients with Mild Cognitive Impairment stratified by Gender

Stroke: vascular and interventional neurology, 2021-11, Vol.1 (S1)

2021

Volltextzugriff (PDF)

Taking the Pulse: perceptions of crime trends and community safety and support for crime control methods in the Canadian Prairies

Journal of community safety & well-being, 2017-06, Vol.2 (2), p.43

2017

Volltextzugriff (PDF)

Abstract 1122‐000029: Pharmacological and Clinical Factors Associated with Gender Difference in Alzheimer Dementia Patients

Stroke: vascular and interventional neurology, 2021-11, Vol.1 (S1)

2021

Volltextzugriff (PDF)

Modeling chemical interaction profiles: II. Molecular docking, spectral data-activity relationship, and structure-activity relationship models for potent and weak inhibitors of cytochrome P450 CYP3A4 isozyme

Molecules (Basel, Switzerland), 2012-03, Vol.17 (3), p.3407-3460

2012

Volltextzugriff (PDF)

Modeling chemical interaction profiles: I. Spectral data-activity relationship and structure-activity relationship models for inhibitors and non-inhibitors of cytochrome P450 CYP3A4 and CYP2D6 isozymes

Molecules (Basel, Switzerland), 2012-03, Vol.17 (3), p.3383-3406

2012

Volltextzugriff (PDF)

Abstract 1122‐000025: Gender in Dementia Patients with Lewy Body Dementia and Parkinson’s Disease with Dementia

Stroke: vascular and interventional neurology, 2021-11, Vol.1 (S1)

2021

Volltextzugriff (PDF)

The benefits of communication between comparative ethology and phylogenetic systematics: a case study using gasterosteid fishes

Canadian journal of zoology, 1988-10, Vol.66 (10), p.2177-2190

1988

Volltextzugriff (PDF)

Modeling of Sensitive Subpopulations and Interindividual Variability in Pharmacokinetics for Health Risk Assessments

Computational Toxicology, 2013, p.45-66

2013

Volltextzugriff (PDF)

Chapter 4 - Modeling of Sensitive Subpopulations and Interindividual Variability in Pharmacokinetics for Health Risk Assessments

Computational Toxicology, 2013, p.45-66

2013

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Zeitschrift / SerieCpt: Pharmacometrics And Systems Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(22)
Buchkapitel
(2)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(9)
Pharmacology & Pharmacy
(7)
Pharmacokinetics
(5)
Biochemistry & Molecular Biology
(4)
Dementia
(4)
Gender Differences
(4)
Methadone
(4)
Neonatal Abstinence Syndrome
(4)
Patients
(4)
Psychotropic Drugs
(4)
Toxicology
(4)
Bayesian Analysis
(3)
Cytochrome P-450 Enzyme System - Metabolism
(3)
Drug Therapy
(3)
Drug Withdrawal
(3)
Infant, Newborn
(3)
Isoenzymes - Metabolism
(3)
Morphine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Applications of Physiologically Based Pharmacokinetic Modeling: Perspectives on the Advantages and Challenges

Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics

The immature rat as a potential model for chemical risks to children: Ontogeny of selected hepatic P450s

Molecular characterization of PoGT8D and PoGT43B, two secondary wall-associated glycosyltransferases in poplar [Populus]

Utilizing pediatric PBPK models to examine factors which contribute to methadone pharmacokinetic variability in neonatal abstinence syndrome patients

The PARVUS gene is expressed in cells undergoing secondary wall thickening and is essential for glucuronoxylan biosynthesis

Sex Differences in Demographic and Pharmacological Factors in Alzheimer Patients With Dementia and Cognitive Impairments

“I realized I was not alone”: A mixed-methods investigation of the implementation of Ubuntu groups to reduce burnout and social isolation in an allopathic medical School in the Southeastern United States

American Society for Pharmacology and Experimental Therapeutics Division for Pharmacology Education at EB2022—Meeting report

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial

Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer's Disease

An Adaptive Blended Learning Model for the Implementation of an Integrated Medical Neuroscience Course During the Covid‐19 Pandemic

Abstract 1122‐000036: Demographic and Pharmacological Characteristics of Alzheimer Dementia Patients with Mild Cognitive Impairment stratified by Gender

Taking the Pulse: perceptions of crime trends and community safety and support for crime control methods in the Canadian Prairies

Abstract 1122‐000029: Pharmacological and Clinical Factors Associated with Gender Difference in Alzheimer Dementia Patients

Modeling chemical interaction profiles: II. Molecular docking, spectral data-activity relationship, and structure-activity relationship models for potent and weak inhibitors of cytochrome P450 CYP3A4 isozyme

Modeling chemical interaction profiles: I. Spectral data-activity relationship and structure-activity relationship models for inhibitors and non-inhibitors of cytochrome P450 CYP3A4 and CYP2D6 isozymes

Abstract 1122‐000025: Gender in Dementia Patients with Lewy Body Dementia and Parkinson’s Disease with Dementia

The benefits of communication between comparative ethology and phylogenetic systematics: a case study using gasterosteid fishes

Modeling of Sensitive Subpopulations and Interindividual Variability in Pharmacokinetics for Health Risk Assessments

Chapter 4 - Modeling of Sensitive Subpopulations and Interindividual Variability in Pharmacokinetics for Health Risk Assessments

Aktive Filter

Suchergebnisse filtern